Clinical Trial Update: Methylphenidate for the Treatment of Gait Impairment in Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating methylphenidate for gait impairment in Parkinson's disease, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: University of Cincinnati | Conditions: Parkinson's Disease, Gait Impairment | Phase 4 | Status: COMPLETED | Results posted: 2015-04-22